Cargando…
Sphingolipids in thyroid eye disease
Graves’ disease (GD) is caused by an autoimmune formation of autoantibodies and autoreactive T-cells against the thyroid stimulating hormone receptor (TSHR). The autoimmune reaction does not only lead to overstimulation of the thyroid gland, but very often also to an immune reaction against antigens...
Autores principales: | Gulbins, Anne, Görtz, Gina-Eva, Gulbins, Erich, Eckstein, Anja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112667/ https://www.ncbi.nlm.nih.gov/pubmed/37082124 http://dx.doi.org/10.3389/fendo.2023.1170884 |
Ejemplares similares
-
Potential involvement of the bone marrow in experimental Graves’ disease and thyroid eye disease
por: Gulbins, Anne, et al.
Publicado: (2023) -
Linsitinib, an IGF-1R inhibitor, attenuates disease development and progression in a model of thyroid eye disease
por: Gulbins, Anne, et al.
Publicado: (2023) -
The Role of Sphingolipids and Ceramide in Pulmonary Inflammation in Cystic Fibrosis
por: Becker, Katrin Anne, et al.
Publicado: (2010) -
OR26-03 Treatment With Linsitinib, An IGF-1 Receptor Inhibitor, Prevents Disease Development And Progression In An Experimental Model Of Thyroid Eye Disease
por: Gulbins, Anne, et al.
Publicado: (2023) -
Sphingolipid Metabolism in Systemic Inflammation
por: Deigner, H. P., et al.
Publicado: (2007)